The etiology and pathogenesis of the inflammatory and fibrotic bile du
ct lesions characteristic of primary sclerosing cholangitis (PSC) is u
nknown, but several lines of evidence support the contention that gene
tic and immunologic factors are involved. Then is an association with
human leukocyte antigens (HLA) with an increased frequency of DR3, DR6
, and DR2 positive haplotypes. DRB3()0101(DR52a) is the most strongly
associated allele in some studies,but the HLA gene conferring the pri
mary HLA associated susceptibility to PSC remains to be established. T
here is an aberrant expression of HLA class II antigens (DR and DP) on
bile duct epithelial cells, with the potential to present antigens to
the surrounding T-lymphocytes. A defective suppressor T-cell function
has been suggested in some studies. The patients may have elevated le
vels of circulating immune complexes, immunoglobulins, and non-organ-s
pecific autoantibodies. Antibodies to perinuclear antigens (pANCA) are
present in about 80% of cases. Increased metabolism of complement C3,
reduced clearance of immune complexes, and increased concentration of
biliary immune complexes have been found. The strong association betw
een PSC and ulcerative colitis (UC) has not been explained. The detect
ion of circulating IgG antibodies against a specific epitope shared by
epithelial cells in the bile ducts and colon in about two-thirds of P
SC patients may be of importance. Portal bacteremia secondary to a dis
eased bowel may possibly contribute to development of liver disease in
UC. Viral infections and toxic and ischemic factors have also been im
plicated in the pathogenesis of PSC. In conclusion, PSC seems to occur
in genetically predisposed individuals, mediated by immunologic mecha
nisms. The primary event triggering the disease development is, howeve
r, unknown.